(IBDV) iShares Trust - iShares - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E7269
IBDV: Corporate Bonds, Investment-Grade Securities, Fixed Income Securities
The iShares iBonds Dec2030 Term Corporate ETF is a targeted maturity ETF that focuses on investment-grade corporate bonds with a maturity date in December 2030. The funds primary objective is to track the performance of its underlying index, which comprises U.S. dollar-denominated bonds issued by U.S. and non-U.S. corporations with a minimum outstanding face value of $300 million.
The ETFs investment strategy involves allocating at least 80% of its assets to the component securities of the underlying index and at least 90% to fixed-income securities, ensuring a high level of consistency with the indexs performance. Given the non-diversified nature of the fund, its performance is closely tied to the credit quality and yield of the underlying bonds.
Analyzing the technical data, we observe that the ETFs price is currently at $21.77, slightly above its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a positive short-term trend. The 200-day simple moving average (SMA200) is at $21.24, suggesting a longer-term uptrend. The Average True Range (ATR) is 0.16, representing a relatively low volatility of 0.74%. Considering these technical indicators, we can anticipate a potential continuation of the uptrend, driven by the ETFs alignment with the overall bond market conditions.
From a fundamental perspective, the ETFs Assets Under Management (AUM) stand at $1847.70 million USD, indicating a reasonable level of investor interest and liquidity. As the fund approaches its target maturity date, we can expect the credit quality of the underlying bonds to remain a key driver of performance. With investment-grade corporate bonds generally considered to be relatively low-risk, we forecast that the ETF will continue to attract investors seeking stable returns, potentially driving the price higher.
Combining technical and fundamental insights, our forecast suggests that the iShares iBonds Dec2030 Term Corporate ETF will likely maintain its upward trajectory, potentially reaching $22.50 by the end of the next quarter, driven by a combination of favorable bond market conditions and investor demand for targeted maturity ETFs.
Additional Sources for IBDV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
IBDV ETF Overview
Market Cap in USD | 1,860m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2020-06-23 |
IBDV ETF Ratings
Growth Rating | 3.41 |
Fundamental | - |
Dividend Rating | 78.6 |
Rel. Strength | -5.33 |
Analysts | - |
Fair Price Momentum | 22.32 USD |
Fair Price DCF | - |
IBDV Dividends
Dividend Yield 12m | 4.69% |
Yield on Cost 5y | 4.72% |
Annual Growth 5y | 33.51% |
Payout Consistency | 100.0% |
Payout Ratio | % |
IBDV Growth Ratios
Growth Correlation 3m | 82.6% |
Growth Correlation 12m | 70% |
Growth Correlation 5y | -39.5% |
CAGR 5y | 0.52% |
CAGR/Max DD 5y | 0.02 |
Sharpe Ratio 12m | 1.59 |
Alpha | 3.60 |
Beta | 0.007 |
Volatility | 4.76% |
Current Volume | 508.6k |
Average Volume 20d | 301.1k |
As of June 29, 2025, the stock is trading at USD 21.94 with a total of 508,618 shares traded.
Over the past week, the price has changed by +0.73%, over one month by +1.41%, over three months by +2.63% and over the past year by +7.87%.
Neither. Based on ValueRay´s Analyses, iShares Trust - iShares is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 3.41 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDV is around 22.32 USD . This means that IBDV is currently overvalued and has a potential downside of 1.73%.
iShares Trust - iShares has no consensus analysts rating.
According to our own proprietary Forecast Model, IBDV iShares Trust - iShares will be worth about 24.1 in June 2026. The stock is currently trading at 21.94. This means that the stock has a potential upside of +9.89%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.1 | 9.9% |